Aggregate lease expense for the Company’s leases for the three months ended June 30, 2026 and 2025 was approximately $0.5 million and $0.6 million, respectively, and aggregate lease expense for the six months ended June 30, 2026 and 2025 was approximately $1.0 million and $1.2 million, respectively. Cash paid for the Company’s leases for the three months ended June 30, 2026 and 2025 was also approximately $0.5 million and $0.6 million, respectively, and cash paid for the six months ended June 30, 2026 and 2025 was approximately $1.0 million and $1.2 million, respectively.

The Company has aggregate lease liabilities of $7.3 million and $7.7 million as of June 30, 2026 and December 31, 2025, respectively, which are comprised primarily of the leases for the Company’s plasma collection centers. As of June 30, 2026, the Company’s operating leases have a weighted-average remaining term of 5.2 years. Scheduled payments under the Company’s lease obligations are as follows (in thousands):